Pharmaceutical Technology

OCTOBER 21, 2024

This trial investigated the potential of Nanoscope Therapeutics' MCO-010 to restore vision in patients with retinitis pigmentosa (RP).

Patients 98

Patients 98

PM360

OCTOBER 31, 2024

[Cedar Knolls, 10/29/2024] — A recent study conducted by PURE , the industry’s premier benchmark for evaluating patient support programs (PSPs), has named the best-in-class PSPs across key therapeutic areas. Kulstad commented: “These results provide an insightful roadmap for the future of patient support programs.

Patients 52

Patients Education Consulting Healthcare 52

Pharma Marketing Network

JUNE 18, 2024

Are you listening to your patient community? We must step forward and be visible, actively engaging in patient communities and embedding the patient voice internally. Show that pharma is driven by more than profit – to build a world that empowers all patients and leaves no one in the dark. It’s not enough.

Pharma 52

Pharma Patients Networking Healthcare 52

Pharmaceutical Technology

AUGUST 1, 2024

During a session at the 2024 Alzheimer’s Association International Conference (AAIC), which concludes today, Ralph Carmona shared his experience of being diagnosed with Mild Cognitive Impairment (MCI) due to Alzheimer’s disease.

Patients 52

Patients 52

Pharmaceutical Technology

JULY 19, 2024

New global projections and advances in HIV therapies are also on the agenda at the 25th International AIDS 2024 meeting.

Patients 64

Patients 64

European Pharmaceutical Review

APRIL 30, 2024

A positive opinion of a marketing authorisation was granted for Altuvoct (efanesoctocog alfa), as a treatment and prophylaxis of bleeding in patients with the rare blood disorder haemophilia A. CHMP meeting highlights: March 2024 The post CHMP meeting highlights: April 2024 appeared first on European Pharmaceutical Review.

Medicine 98

Medicine Consulting Patients FDA 98

MedCity News

JANUARY 8, 2024

Medicare Advantage patients without a primary care physician are perhaps the greatest risk to health plans in 2024. Health plans must adopt best practices to reach and engage MA patients, especially those with multiple, complex conditions. Here are six best practices to consider.

Physicians 101

Physicians Patients 101

Fierce Pharma

JUNE 2, 2024

A 50% improvement on the time patients could live without disease progression would typically be considered remarkable for a new drug. A 50% improvement on the time patients could live without disease progression would typically be considered remarkable for a new drug. AstraZeneca’s Tagrisso just delivered an 84% improvement. |

Patients 307

Patients 307

PharmExec

OCTOBER 16, 2024

In the pharmaceutical industry, patient engagement should be centered in health education, communication, and strategy during drug discovery and throughout the product lifecycle. Cheryl Lubbert, CEO of Reverba, discusses the importance of a patient-first mindset in the industry.

Patients 52

Patients Education Pharmaceutical 52

European Pharmaceutical Review

FEBRUARY 26, 2024

At its February 2024 meeting, the EMA’s human medicines committee (CHMP) recommended the extension of marketing authorisations for six treatments, and positive opinions for the approval of ten medicines. Clinical data showed approximately 60 percent reductions in plasma NfL concentrations in patients given Qalsody compared to placebo.

Medicine 98

Medicine Patients Marketing Pharmaceutical 98

Pharma Marketing Network

DECEMBER 6, 2023

The moment is now to prove ourselves as a trusted industry ally and the ultimate safe harbor for patients.  Delivering aligned value to HCPs, patients, payers and regulators.  We must adapt to evolving payer needs, empower HCPs with crucial insights, bridge regulatory gaps and co-create with patients.

Pharma 52

Pharma Networking Marketing Medicine 52

European Pharmaceutical Review

OCTOBER 3, 2024

The post <em>European Pharmaceutical Review </em> Issue 4 2024 appeared first on European Pharmaceutical Review. Preparing for the impact of EU GMP Annex 1 on primary packaging Niamh Bissett and Dr Ana Kuschel West Pharmaceutical Services, Inc. Login or create an account to download your copy of our Issue now!

Pharmaceutical 59

Pharmaceutical Consulting Manufacturing FDA 59

European Pharmaceutical Review

JULY 5, 2024

Following the Labour Party’s win yesterday in the UK 2024 General Election, industry representatives have voiced their opinions on what this could mean for the future of the pharmaceutical industry under the new government. EU pharmacovigilance is stronger with the UK, and UK research is stronger with the EU.”

Pharma 98

Pharma Government Safety Pharmaceutical manufacturing 98

European Pharmaceutical Review

MAY 25, 2023

CPHI’s Pharmapack Awards 2024 are open for submissions. The Pharmapack Awards 2024 (January 24-25 2024) will be held during the event’s opening day. The three award categories for the Health Product Awards 2024 are: Patient-Centric Design Award Eco-Design Award Animal Health.

Pharma 95

Pharma Distribution Pharmaceutical Patients 95

European Pharmaceutical Review

JANUARY 30, 2024

The European Medicine Agency’s human medicines committee (CHMP) recommended marketing authorisations for the regulatory approval of three medicines at its January 2024 meeting last week. CHMP’s September 2023 meeting highlights The post CHMP meeting highlights: January 2024 appeared first on European Pharmaceutical Review.

Medicine 98

Medicine Marketing Safety Pharmaceutical 98

Impetus Digital

JUNE 17, 2024

Simulation-Based Learning Simulation-based learning can allow students to practice clinical skills and make decisions in life-like scenarios without the risk of harming actual patients. It can also simulate patient interactions and provide instant feedback to help HCPs improve their efficiency and accuracy when diagnosing and prescribing.

Education 109

Education Medical Training Media 109

European Pharmaceutical Review

OCTOBER 28, 2024

Biologic with rapid onset of action Week 12 results showed that over fifty percent of patients treated with subcutaneous TREMFYA at Weeks 0, 4, and 8 obtained clinical remission over placebo, at 21.4 These Phase III results were presented at the American College of Gastroenterology (ACG) 2024 conference. percent, respectively.

Medicine 59

Medicine Patients Management Leads 59

Pharmacy Times

NOVEMBER 14, 2024

Community pharmacists are playing an increasing role in sexual and reproductive health services and can provide that trustworthy information to patients.

Patients 51

Patients 51

MedCity News

DECEMBER 26, 2023

In looking ahead to 2024, the healthcare industry stands at the cusp of a transformative era of transparency. With impending regulatory changes and growing consumer empowerment, the landscape is poised for continued meaningful progress.

Healthcare 101

Healthcare Healthcare Patients 101

European Pharmaceutical Review

AUGUST 15, 2023

CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. The post CPHI to return to Milan in 2024 appeared first on European Pharmaceutical Review.

Manufacturing 98

Manufacturing Pharma Pharmaceutical Pharmaceutical research 98

Eversana Intouch

NOVEMBER 20, 2023

As we step into 2024, the realm of market access undergoes dynamic shifts influenced by technological advancements, policy changes, and evolving consumer behaviors. Pharma/Biotech companies will continue to tailor their market access strategies locally to maximize patient outcomes and drive commercial value.

Marketing 105

Marketing Healthcare Healthcare Pharma 105

Pharmaceutical Commerce

OCTOBER 2, 2024

In this paper, UBC's Senior Clinical Program Manager, Amanda Scholz, MHA, BSN, RN, discusses the important role that clinical adherence programs play in empowering patients and bolster persistence to prescribed life-changing medications throughout their journey.

Patients 52

Patients Management Medical 52

PM360

FEBRUARY 23, 2024

It means the people who live and breathe this industry, who spend countless hours obsessing over the right words (and even the right fonts), who have had similar debates on the best ways to reach patients or doctors, who can’t stop tinkering with various aspects of the art until it is just right—these are the people who picked the best creatives of (..)

Pharma 52

Pharma Media Sales Healthcare 52

European Pharmaceutical Review

JUNE 28, 2024

Data integrity and AI: how pharma can build a data-driven future LabVantage Solutions explains that data integrity remains a core responsibility – and challenge – as pharmaceutical organisations seek to leverage AI and data lakes to grow, innovate and serve patients. Interested? Register your details to access this exclusive content.

Biopharma 52

Biopharma Manufacturing Safety Pharmaceutical 52

Clarivate

APRIL 18, 2024

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. More recent developments provide a look into Amazon’s interest in treating patients with chronic conditions, including a pharmacy consultation pilot for high-risk seniors with complex medical needs.

Retail 52

Retail Healthcare Healthcare Physicians 52

European Pharmaceutical Review

OCTOBER 31, 2024

Announcement of the UK Government’s 2024 Autumn Budget on 30 October marks the first Labour budget in 14 years. UK manufacturing and R&D to benefit from new £360m investment The post Life sciences response to 2024 Autumn Budget appeared first on European Pharmaceutical Review.

Manufacturing 52

Manufacturing Medical science Medicine Engineering 52

Pharma Marketing Network

DECEMBER 12, 2023

Upcoming Informa Connect Events: Speaker Programs Summit – February 26-28, 2024 Event Name: Rare Disease Summit – March 19-21, 2024 PAP – Patient Assistance & Access Programs – March 19-21, 2024 Hub and Specialty Pharmacy Models East – March 19-21, 2024 Pharma Forum – March 24-27, 2024 Pharmaceutical Compliance Congress (..)

Education 40

Education Networking Pharma Pharmaceutical 40

Pharmaceutical Commerce

MARCH 20, 2024

In an interview with Pharma Commerce Associate Editor Don Tracy, Amy Niles, Chief Mission Officer, PAN Foundation offers her thoughts on the session and feedback from the audience at PAP 2024 in Philadelphia.

Patients 52

Patients Pharma 52

PM360

OCTOBER 22, 2024

Improving our collective understanding of the patient’s overall healthcare experience is necessary to effectively deliver prescription support. How can we ensure that vital prescription information reaches patients when they need it? Where and how you message HCPs and patients must synchronize with when they are engaged.

Medical 52

Medical Patients Prescription Doctors 52

Healthcare Success

JANUARY 2, 2024

Now that the holidays have drawn to a close, it’s time to return to your 2024 marketing plan and make adjustments that ensure your business is taking advantage of the latest trends in healthcare marketing to reach patients and HCPs more effectively and make a lasting impression.

Healthcare 78

Healthcare Healthcare Marketing Healthcare Provider 78

Nixon Gwilt Law

NOVEMBER 30, 2023

Reimbursement for Community Health Integration, Social Determinants Risk Assessment, and Principal Illness Navigation On November 2, the Centers for Medicare and Medicaid Services (“CMS”) released the 2024 Medicare Physician Fee Schedule (“2024 MPFS”) final rule.

Physicians 52

Physicians Patients Training Management 52

Nixon Gwilt Law

NOVEMBER 30, 2023

Reimbursement for Community Health Integration, Social Determinants Risk Assessment, and Principal Illness Navigation On November 2, the Centers for Medicare and Medicaid Services (“CMS”) released the 2024 Medicare Physician Fee Schedule (“2024 MPFS”) final rule.

Physicians 52

Physicians Patients Management Training 52

MedCity News

FEBRUARY 14, 2024

2024 presents an exciting yet challenging landscape for global pharma marketers.

Marketing 97

Marketing Pharma Pharmaceutical Patients 97

LEVO Health

DECEMBER 28, 2023

As we look toward 2024, video marketing is set to become a critical component of a comprehensive marketing strategy. This approach tailors the viewing experience to individual patients, considering their unique needs, preferences, and behaviors. As we look ahead to 2024, AI and machine learning are poised to play an even larger role.

Marketing 52

Marketing Healthcare Healthcare Education 52

Pharmaceutical Commerce

MARCH 19, 2024

Panel discusses PAN Foundation’s inaugural “State of Patient Access” report, and dives deep into patient challenges.

Patients 52

Patients 52

PM360

MARCH 27, 2024

In 2024, we will start seeing more of these programs hit the market, solidifying the viability of mRNA as a powerful and versatile therapeutic platform. In light of this dramatic change, what else can we anticipate from the field in 2024? In 2024, we’ll see the fruits of these efforts.

Manufacturing 52

Manufacturing Marketing Patients 52

European Pharmaceutical Review

MAY 29, 2024

Furthermore, Biomica highlighted that one patient demonstrated partial response and is “actively responding to treatment”. The combination therapy halted disease progression in 64 percent of patients. Sustained clinical benefit was observed in 55 percent of patients.

Patients 98

Patients Safety Medicine Medical 98